Literature DB >> 31420777

Therapeutic targets for endothelial dysfunction in vascular diseases.

Diem Thi Ngoc Huynh1, Kyung-Sun Heo2,3.   

Abstract

Vascular endothelial cells are located on the surface of the blood vessels. It has been recognized as an important barrier to the regulation of vascular homeostasis by regulating the blood flow of micro- or macrovascular vessels. Indeed, endothelial dysfunction is an initial stage of vascular diseases and is an important prognostic indicator of cardiovascular and metabolic diseases such as atherosclerosis, hypertension, heart failure, or diabetes. Therefore, in order to develop therapeutic targets for vascular diseases, it is important to understand the key factors involved in maintaining endothelial function and the signaling pathways affecting endothelial dysfunction. The purpose of this review is to describe the function and underlying signaling pathway of oxidative stress, inflammatory factors, shear stress, and epigenetic factors in endothelial dysfunction, and introduce recent therapeutic targets for the treatment of cardiovascular diseases.

Entities:  

Keywords:  Atherosclerosis; Endothelial dysfunction; Epigenetic factors; Inflammation; Oxidative stress; Shear stress

Mesh:

Year:  2019        PMID: 31420777     DOI: 10.1007/s12272-019-01180-7

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  10 in total

Review 1.  Role of mitochondrial dynamics and mitophagy of vascular smooth muscle cell proliferation and migration in progression of atherosclerosis.

Authors:  Diem Thi Ngoc Huynh; Kyung-Sun Heo
Journal:  Arch Pharm Res       Date:  2021-11-07       Impact factor: 4.946

Review 2.  Biomarkers of Oxidative Stress Tethered to Cardiovascular Diseases.

Authors:  Poojarani Panda; Henu Kumar Verma; Saikrishna Lakkakula; Neha Merchant; Fairrul Kadir; Shamsur Rahman; Mohammad Saffree Jeffree; Bhaskar V K S Lakkakula; Pasupuleti Visweswara Rao
Journal:  Oxid Med Cell Longev       Date:  2022-06-24       Impact factor: 7.310

Review 3.  β-Hydroxybutyrate in Cardiovascular Diseases : A Minor Metabolite of Great Expectations.

Authors:  Shao Wei; Liu Binbin; Wu Yuan; Zhang Zhong; Lin Donghai; Huang Caihua
Journal:  Front Mol Biosci       Date:  2022-06-13

4.  Ginsenoside Rh1 inhibits tumor growth in MDA-MB-231 breast cancer cells via mitochondrial ROS and ER stress-mediated signaling pathway.

Authors:  Yujin Jin; Diem Thi Ngoc Huynh; Kyung-Sun Heo
Journal:  Arch Pharm Res       Date:  2022-03-24       Impact factor: 4.946

5.  Ginsenoside Rh1 Inhibits Angiotensin II-Induced Vascular Smooth Muscle Cell Migration and Proliferation through Suppression of the ROS-Mediated ERK1/2/p90RSK/KLF4 Signaling Pathway.

Authors:  Diem Thi Ngoc Huynh; Yujin Jin; Dung Van Nguyen; Chang-Seon Myung; Kyung-Sun Heo
Journal:  Antioxidants (Basel)       Date:  2022-03-27

Review 6.  Oxidative Stress in Cardiovascular Diseases: Still a Therapeutic Target?

Authors:  Thomas Senoner; Wolfgang Dichtl
Journal:  Nutrients       Date:  2019-09-04       Impact factor: 5.717

Review 7.  Extracellular Endothelial Cell-Derived Vesicles: Emerging Role in Cardiac and Vascular Remodeling in Heart Failure.

Authors:  Alexander E Berezin; Alexander A Berezin
Journal:  Front Cardiovasc Med       Date:  2020-04-15

Review 8.  Histone Deacetylases (HDACs) and Atherosclerosis: A Mechanistic and Pharmacological Review.

Authors:  Xiaona Chen; Yanhong He; Wenjun Fu; Amirhossein Sahebkar; Yuhui Tan; Suowen Xu; Hong Li
Journal:  Front Cell Dev Biol       Date:  2020-11-12

Review 9.  Effects of REDOX in Regulating and Treatment of Metabolic and Inflammatory Cardiovascular Diseases.

Authors:  Kai Wang; Yanhan Dong; Jing Liu; Lili Qian; Tao Wang; Xiangqian Gao; Kun Wang; Luyu Zhou
Journal:  Oxid Med Cell Longev       Date:  2020-11-17       Impact factor: 6.543

10.  Dihydromyricetin Improves Endothelial Dysfunction in Diabetic Mice via Oxidative Stress Inhibition in a SIRT3-Dependent Manner.

Authors:  Yu-Yun Hua; Yue Zhang; Wei-Wei Gong; Yue Ding; Jie-Ru Shen; Hua Li; Yun Chen; Guo-Liang Meng
Journal:  Int J Mol Sci       Date:  2020-09-13       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.